- Citizens Financial‘s underlying earnings per share (EPS) for the third quarter matched estimates at 79 cents.
- The reported EPS for the third quarter was slightly lower at 77 cents.
- The third quarter results were affected by forward-starting swaps and fees that are postponed to the fourth quarter.
- The company anticipates a strong performance in the fourth quarter and a positive outlook for 2025.
- Analyst ratings for the company include 11 buys, 10 holds, and 1 sell.
A look at Citizens Financial Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 4 | |
Growth | 3 | |
Resilience | 3 | |
Momentum | 5 | |
OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma’s Smart Scores, Citizens Financial Group Inc. shows promise for long-term investors. With a top-notch Value score of 5, the company is seen as undervalued in the market, potentially offering good investment opportunities. Its solid Dividend score of 4 indicates a stable dividend payout, making it an attractive pick for income investors. While the Growth and Resilience scores are moderate at 3, the Momentum score of 5 suggests strong positive market sentiment towards the company.
Citizens Financial Group Inc. is a commercial banking powerhouse that caters to both retail and institutional customers, providing a wide range of financial services including consumer loans, commercial loans, mortgages, deposits, internet banking, and trust services. With high scores in key areas like Value and Momentum, the company seems well-positioned for long-term success, offering a blend of value and growth potential for investors looking to capitalize on its strengths.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars